Air Liquide Healthcare, more specifically its medical devices division, has received an award for the quality of its innovative devices and services and its contribution to improve patient’s quality of life.

On 12th February (2019), in Brussels, EURODIS recognised the players that have contributed to advancing the cause of rare diseases in Europe during its annual Black Pearl Awards ceremony.

Air Liquide Healthcare was nominated in Health Technology category by the French association AFM-Téléthon, a member of EURODIS-Rare Disease.

Many who live with rare diseases and experience respiratory issues benefit for the Tier One company’s innovations.

Air Liquide Healthcare has developed a nasal mask for children that allows them to speak with ease, wear glasses when needed to improve their quality of day-to-day life.

Since 2012, EURODIS-Rare Diseases Europe have hosted the Black Pearl Awards ceremony to recognise major achievement and the commitment of patient advocacy groups, public policy makers, scientists, businesses, and media that strive to make a difference for the rare disease community.